The study covered in this summary was published on ResearchSquare.com as a preprint and has not yet been peer-reviewed. A comprehensive understanding of the relationship between acute AF and risk for ...

The registry data suggest improved outcomes without safety concerns, but confirmatory RCTs are needed, a researcher says.

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window An earlier start ...

When treating patients with acute ischemic stroke within 4.5 hours of symptom onset, tenecteplase provides noninferior outcomes compared with alteplase (Activase; Genentech), with similar safety, ...

Please provide your email address to receive an email when new articles are posted on . Tenecteplase was noninferior to alteplase for acute ischemic stroke when given within 4.5 hours of symptom onset ...

Trials have evaluated the use of clopidogrel and aspirin to prevent stroke after an ischemic stroke or transient ischemic attack (TIA). In a previous trial, ticagrelor was not better than aspirin in ...

Please provide your email address to receive an email when new articles are posted on . Butylphthalide improved 90-day clinical outcomes in those with acute ischemic stroke who also received IV ...

In certain patients with mild-to-moderate acute ischemic stroke, dual antiplatelet therapy (DAPT) with aspirin and clopidogrel (Plavix) reduced early neurologic deterioration better than aspirin alone ...

MINNEAPOLIS--(BUSINESS WIRE)--DiaMedica Therapeutics Inc. (Nasdaq: DMAC) announced that it recently received written responses from the FDA following a Type B Pre-IND meeting request that the Company ...

CANTON, Ohio--(BUSINESS WIRE)--US Acute Care Solutions (USACS) is proud to announce a collaboration with the University of Pennsylvania Health System (Penn Medicine) to incorporate the USACS ...